B
HLVX

Braidwell’s HilleVax HLVX Stock Holding History

Braidwell’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,064,000
Closed -$1.87M – 83
2024
Q3 		$1.87M Buy
+1,064,000
New +$2.73M 0.05% 78
2024
Q1 		– Sell
-203,407
Closed -$3.26M – 75
2023
Q4 		$3.26M Sell
203,407
-1,245,839
-86% -$16.6M 0.12% 70
2023
Q3 		$19.5M Buy
1,449,246
+200,000
+16% +$2.81M 0.62% 53
2023
Q2 		$21.5M Sell
1,249,246
-370,970
-23% -$5.75M 0.7% 52
2023
Q1 		$26.8M Hold
1,620,216
– – 0.88% 46
2022
Q4 		$27.1M Buy
+1,620,216
New +$29.3M 0.91% 42

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $2.4B AUM 7.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Braidwell's HLVX Position: Q4 2024 in Review

Braidwell sold out of HilleVax (HLVX) in Q4 2024, closing a stake of 1,064,000 shares — an estimated $1.87M sold.

Braidwell first reported a position in HLVX in Q4 2022 and held it in 6 quarters. The position peaked at $27.1M in Q4 2022. 76 funds tracked by Wall St. Rank hold HLVX as of Q4 2024.

  • Braidwell reported no remaining HilleVax position as of Q4 2024 after selling out during the quarter.
  • Braidwell sold 1,064,000 HilleVax shares in Q4 2024, an estimated $1.87M.
  • Braidwell first reported a position in HilleVax in Q4 2022 and held it in 6 quarters.
  • Braidwell's HilleVax position peaked at $27.1M in Q4 2022.
  • 76 funds tracked by Wall St. Rank held HilleVax as of Q4 2024.

Based on Braidwell's 13F filing for Q4 2024, filed 14 Feb 2025.